Published in J Biol Chem on December 08, 1995
Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol (2003) 3.34
Structural insight into the altered substrate specificity of human cytochrome P450 2A6 mutants. Arch Biochem Biophys (2007) 1.06
Using a homology model of cytochrome P450 2D6 to predict substrate site of metabolism. J Comput Aided Mol Des (2010) 0.88
Phe120 contributes to the regiospecificity of cytochrome P450 2D6: mutation leads to the formation of a novel dextromethorphan metabolite. Biochem J (2004) 0.88
An analysis of the role of active site protic residues of cytochrome P-450s: mechanistic and mutational studies on 17alpha-hydroxylase-17,20-lyase (P-45017alpha also CYP17). Biochem J (1998) 0.88
Influence of phenylalanine-481 substitutions on the catalytic activity of cytochrome P450 2D6. Biochem J (2001) 0.88
Regioselective oxidation of phospho-NSAIDs by human cytochrome P450 and flavin monooxygenase isoforms: implications for their pharmacokinetic properties and safety. Br J Pharmacol (2012) 0.85
Determinants of the substrate specificity of human cytochrome P-450 CYP2D6: design and construction of a mutant with testosterone hydroxylase activity. Biochem J (1998) 0.85
Influence of amino acid residue 374 of cytochrome P-450 2D6 (CYP2D6) on the regio- and enantio-selective metabolism of metoprolol. Biochem J (1996) 0.84
Comparative in vitro metabolism of phospho-tyrosol-indomethacin by mice, rats and humans. Biochem Pharmacol (2013) 0.81
Functional characterization of a first avian cytochrome P450 of the CYP2D subfamily (CYP2D49). PLoS One (2012) 0.81
Re-engineering of CYP2C9 to probe acid-base substrate selectivity. Drug Metab Dispos (2008) 0.78
Role of conserved Asp293 of cytochrome P450 2C9 in substrate recognition and catalytic activity. Biochem J (2003) 0.78
Evidence that serine 304 is not a key ligand-binding residue in the active site of cytochrome P450 2D6. Biochem J (2000) 0.78
The in vitro metabolism of phospho-sulindac amide, a novel potential anticancer agent. Biochem Pharmacol (2014) 0.78
Recent Structural Insights into Cytochrome P450 Function. Trends Pharmacol Sci (2016) 0.77
A strategy for the rapid multiple alignment of protein sequences. Confidence levels from tertiary structure comparisons. J Mol Biol (1987) 19.30
Studies in the biochemistry of micro-organisms: The metabolic products of the Penicillium brevi-compactum series. Biochem J (1932) 11.42
Confidential inquiry into quality of care before admission to intensive care. BMJ (1998) 11.32
Enhanced genome annotation using structural profiles in the program 3D-PSSM. J Mol Biol (2000) 10.87
Studies in the biochemistry of micro-organisms: The metabolic products of Penicillium Charlesii G. Smith. Biochem J (1934) 10.22
Prediction of protein secondary structure and active sites using the alignment of homologous sequences. J Mol Biol (1987) 9.74
Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. A new mould metabolic product-terrein. Biochem J (1935) 7.74
Studies in the biochemistry of micro-organisms: The metabolic products of Aspergillus terreus Thom. Part II. Two new chlorine-containing mould metabolic products, geodin and erdin. Biochem J (1936) 6.60
Hours, volume, and type of work of preregistration house officers. BMJ (1990) 5.68
Enhancement of protein modeling by human intervention in applying the automatic programs 3D-JIGSAW and 3D-PSSM. Proteins (2001) 4.85
Modelling protein docking using shape complementarity, electrostatics and biochemical information. J Mol Biol (1997) 4.69
A phase I evaluation of the safety and immunogenicity of vaccination with recombinant gp160 in patients with early human immunodeficiency virus infection. Military Medical Consortium for Applied Retroviral Research. N Engl J Med (1991) 4.23
Studies in the biochemistry of micro-organisms: The metabolic products of Byssochlamys fulva Olliver and Smith. Biochem J (1933) 3.74
Analysis of the relationship between side-chain conformation and secondary structure in globular proteins. J Mol Biol (1987) 3.63
Evaluation and improvements in the automatic alignment of protein sequences. Protein Eng (1989) 3.57
Crystallographic studies of the dynamic properties of lysozyme. Nature (1979) 3.30
Inhibition of antipyrine metabolism by beta-adrenoceptor antagonists. Br J Clin Pharmacol (1981) 3.07
Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth (1987) 3.05
Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry (1998) 3.02
Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes. J Exp Med (1987) 3.02
Knowledge-based prediction of protein structures and the design of novel molecules. Nature (1987) 2.99
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
Oxidation phenotype--a major determinant of metoprolol metabolism and response. N Engl J Med (1982) 2.72
Serotonin in aging, late-life depression, and Alzheimer's disease: the emerging role of functional imaging. Neuropsychopharmacology (1998) 2.70
Structure of an XRCC1 BRCT domain: a new protein-protein interaction module. EMBO J (1998) 2.68
Postoperative wound infection: a computer analysis. Br J Surg (1971) 2.67
PrP genotype and agent effects in scrapie: change in allelic interaction with different isolates of agent in sheep, a natural host of scrapie. J Gen Virol (1994) 2.63
Left-handed polyproline II helices commonly occur in globular proteins. J Mol Biol (1993) 2.62
Identification and analysis of domains in proteins. Protein Eng (1995) 2.54
Use of pair potentials across protein interfaces in screening predicted docked complexes. Proteins (1999) 2.49
Sources and types of referral to a haematology department. Health Trends (1992) 2.48
Symptoms after primary immunisation with DTP and with DT vaccine. Lancet (1984) 2.48
Automated structure-based prediction of functional sites in proteins: applications to assessing the validity of inheriting protein function from homology in genome annotation and to protein docking. J Mol Biol (2001) 2.46
The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol (1993) 2.44
Purchasing 'legal highs' on the Internet--is there consistency in what you get? QJM (2010) 2.43
Determination of debrisoquine and its 4-hydroxy metabolite in biological fluids by gas chromatography with flame-ionization and nitrogen-selective detection. J Chromatogr (1977) 2.43
Identification and application of the concepts important for accurate and reliable protein secondary structure prediction. Protein Sci (1996) 2.42
Amiodarone pharmacokinetics. Am Heart J (1983) 2.42
Metformin kinetics in healthy subjects and in patients with diabetes mellitus. Br J Clin Pharmacol (1981) 2.38
Selection of an obstetric data base for a microcomputer and its use for on-line production of birth notification forms, discharge summaries and perinatal audit. Br J Obstet Gynaecol (1983) 2.36
Side-chain conformational entropy in protein folding. Protein Sci (1995) 2.35
Does cerebral blood flow decline in healthy aging? A PET study with partial-volume correction. J Nucl Med (2000) 2.33
Rapid refinement of protein interfaces incorporating solvation: application to the docking problem. J Mol Biol (1998) 2.30
Empirical scale of side-chain conformational entropy in protein folding. J Mol Biol (1993) 2.29
The binding site on ICAM-1 for Plasmodium falciparum-infected erythrocytes overlaps, but is distinct from, the LFA-1-binding site. Cell (1992) 2.29
Echocardiographic measurement of the normal adult right ventricle. Br Heart J (1986) 2.16
Studies in the biochemistry of micro-organisms: Fumaryl-dl-alanine (fumaromono-dl-alanide), a metabolic product of Penicillium resticulosum sp.nov. Biochem J (1942) 2.13
Should we patch corneal abrasions? A meta-analysis. J Fam Pract (1998) 2.12
Epidural anaesthesia and analgesia: better outcome after major surgery?. Growing evidence suggests so. BMJ (1999) 2.10
Inhibition of oxidative drug metabolism by beta-adrenoceptor antagonists in related to their lipid solubility. Br J Clin Pharmacol (1981) 2.08
Reversible restoration of the birefringence of cold-treated, isolated mitotic apparatus of surf clam eggs with chick brain tubulin. Nature (1974) 2.08
Science, medicine, and the future: Pharmacogenetics. BMJ (2000) 2.06
Similarity in membrane proteins. Nature (1989) 2.05
Pharmacokinetics and metabolism of sildenafil in mouse, rat, rabbit, dog and man. Xenobiotica (1999) 2.03
Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet (1989) 2.02
A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature (1990) 2.01
Antibiotics and surgery for vesicoureteric reflux: a meta-analysis of randomised controlled trials. Arch Dis Child (2003) 1.99
Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology (1991) 1.92
Accuracy of burn size estimation and subsequent fluid resuscitation prior to arrival at the Yorkshire Regional Burns Unit. A three year retrospective study. Burns (1999) 1.92
Individual risk factors for hip osteoarthritis: obesity, hip injury, and physical activity. Am J Epidemiol (1998) 1.90
Oesophageal apoplexy. Lancet (1974) 1.88
Benchmarking PSI-BLAST in genome annotation. J Mol Biol (1999) 1.87
Supersites within superfolds. Binding site similarity in the absence of homology. J Mol Biol (1998) 1.87
Ward design in relation to postoperative wound infection. I. Br Med J (1971) 1.85
New algorithm to model protein-protein recognition based on surface complementarity. Applications to antibody-antigen docking. J Mol Biol (1992) 1.85
Recognition of analogous and homologous protein folds: analysis of sequence and structure conservation. J Mol Biol (1997) 1.83
National symptom surveillance using calls to a telephone health advice service--United Kingdom, December 2001-February 2003. MMWR Morb Mortal Wkly Rep (2004) 1.82
An automated classification of the structure of protein loops. J Mol Biol (1997) 1.77
Model building by comparison at CASP3: using expert knowledge and computer automation. Proteins (1999) 1.76
The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma. Gut (2005) 1.73
Use of capillary blood in measurement of arterial PO2. Br Med J (1968) 1.73
Neurofilaments are transported rapidly but intermittently in axons: implications for slow axonal transport. J Neurosci (2000) 1.73
Binding of anilide-type local anesthetics in human plasma. I. Relationships between binding, physicochemical properties, and anesthetic activity. Anesthesiology (1970) 1.71
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol (1992) 1.71
Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease. Diabetes (2001) 1.70
Polymorphic hydroxylation of debrisoquine. Lancet (1977) 1.69
A continuum model for protein-protein interactions: application to the docking problem. J Mol Biol (1995) 1.68
Genetic analysis of the human cytochrome P450 CYP2C9 locus. Pharmacogenetics (1996) 1.67
On the conformation of proteins: the handedness of the connection between parallel beta-strands. J Mol Biol (1977) 1.66
Plasma concentrations of local anaesthetics after interscalene brachial plexus block. Br J Anaesth (1977) 1.66
Preclinical and clinical pharmacology of Rosuvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor. Am J Cardiol (2001) 1.66
Changing epidemiology and ecology of highly pathogenic avian H5N1 influenza viruses. Avian Dis (2007) 1.65
ABC of intensive care. Criteria for admission. BMJ (1999) 1.65
Metoprolol metabolism and debrisoquine oxidation polymorphism--population and family studies. Br J Clin Pharmacol (1985) 1.64
An analysis of conformational changes on protein-protein association: implications for predictive docking. Protein Eng (1999) 1.63
Repeatability and validity of an upper limb and neck discomfort questionnaire: the utility of the standardized Nordic questionnaire. Occup Med (Lond) (1999) 1.62
CT diagnostic features of Alzheimer disease: importance of the choroidal/hippocampal fissure complex. AJNR Am J Neuroradiol (1990) 1.62
Raised mortality from lung cancer and high sex ratios of births associated with industrial pollution. Br J Ind Med (1985) 1.62
CYT387, a selective JAK1/JAK2 inhibitor: in vitro assessment of kinase selectivity and preclinical studies using cell lines and primary cells from polycythemia vera patients. Leukemia (2009) 1.61
Physicians' knowledge of cost: the case of diagnostic tests. Inquiry (1976) 1.60
Analysis and prediction of the location of catalytic residues in enzymes. Protein Eng (1988) 1.59
A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK. J Clin Pharm Ther (2006) 1.58
Neu receptor dimerization. Nature (1989) 1.58